Focusing on international expansion to Canada and America in healthcare at BIOEurope Spring (March 21, 2017)

Submitted by Alina Danieles… on 17 March 2017

Canada is a country presenting interesting assets for European healthcare companies undergoing international expansion, as expressed by the SME members of the bioXclusters+ regions, Auvergne-Rhône-Alps (Lyonbiopole), Bavaria (BioM), Catalonia (Biocat) and  Piedmont (bioPmed). In order to build up collaboration opportunities, the bioXclusters+ alliance, the European Strategic Cluster Partnership on Personalised Healthcare – co-funded by the COSME Programme of the European Union -, has started connection with TOHealth!, an industry-led public private partnership, working as the Toronto Cluster organisationThe connection has been officially formalised by the signature of a mutual collaboration MoU between TOHealth!  and bioXclusters plus in December 2016 for building bioXclusters+ gateways in Canada.

The joint activity is the organisation of a session entitled "Transatlantic cooperation in Precision Medicine: an example from Canada & Europe M&A’s"  within BIO-Europe Spring 2017, in Barcelona on March 21st, 2017, 12:00 – 13.30 a.m. The purpose is to compare business environments for the development and internationalization of personalized and precision medicine between Canada and Europe. Cluster representatives will take part to share best practices and main actors of a succeded business expansion case story across the Atlantic Ocean. BIO-Europe Spring (BES) is one of the main partnering events in Europe. Next edition, BES will take place in Barcelona from 20th to 22nd of March. This fair will be gathering more than 2,500 professionals and 1,300 companies from biotech, pharma and financing sectors. More information here.

Third Country
Share this Article